BANK OF AMERICA CORP /DE/ - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17,560,504
-28.6%
103,853
-8.4%
0.00%0.0%
Q2 2023$24,589,705
-61.0%
113,395
-67.3%
0.00%
-66.7%
Q1 2023$63,063,955
+358.1%
347,192
+395.6%
0.01%
+200.0%
Q4 2022$13,766,003
+7.6%
70,056
+23.1%
0.00%0.0%
Q3 2022$12,799,000
+51.6%
56,906
-14.7%
0.00%
+100.0%
Q2 2022$8,441,000
-23.1%
66,722
-22.9%
0.00%0.0%
Q1 2022$10,976,000
+85.8%
86,561
+91.9%
0.00%0.0%
Q4 2021$5,907,000
+95.9%
45,099
+83.0%
0.00%
Q3 2021$3,016,000
+7.9%
24,648
+0.6%
0.00%
Q2 2021$2,795,000
-22.7%
24,512
-18.5%
0.00%
Q1 2021$3,617,000
+46.0%
30,088
+23.3%
0.00%
Q4 2020$2,478,000
-16.6%
24,393
-36.6%
0.00%
Q3 2020$2,973,000
-7.1%
38,451
+33.9%
0.00%
Q2 2020$3,199,000
+135.4%
28,712
+52.2%
0.00%
Q1 2020$1,359,000
+176.8%
18,869
+189.5%
0.00%
Q4 2019$491,000
+1069.0%
6,517
+149.2%
0.00%
Q3 2019$42,000
+366.7%
2,615
+483.7%
0.00%
Q2 2019$9,0004480.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$142,043,93358.49%
Nan Fung Group Holdings Ltd 225,688$40,993,96827.90%
Sofinnova Investments, Inc. 1,773,124$322,070,24320.60%
Artia Global Partners LP 88,831$16,135,2635.96%
DAFNA Capital Management LLC 78,573$14,272,0004.28%
First Light Asset Management, LLC 243,675$44,261,1273.98%
CATALYST PRIVATE WEALTH, LLC 21,837$3,966,4732.74%
Sands Capital Ventures, LLC 58,895$10,697,6882.64%
ARCH Venture Management, LLC 30,000$5,449,2002.63%
Logos Global Management LP 100,000$18,164,0002.60%
View complete list of KARUNA THERAPEUTICS INC shareholders